Cipherome, Inc.
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia (NCT04770922) | Cipherome, Inc. | 2021-02-23 |
| DOAC ADRs Retrospective Study on Genetic Variations (NCT04580589) | Cipherome, Inc. | 2021-02-01 |
| Evaluating Pharmacogenomic Variants for Cardiology Therapeutics (NCT04702113) | Cipherome, Inc. | 2020-12-03 |
| Association Between Genetic Variant Scores and P2Y12 Inhibitor Effects (NCT04580602) | Cipherome, Inc. | 2020-10-07 |
| Association Between Genetic Variant Scores and DOACs (DARES2) (NCT04597593) | Cipherome, Inc. | 2020-10-07 |
| DOAC ADRs Retrospective Study (NCT04247919) | Cipherome, Inc. | 2020-01-10 |
| Association Between Genetic Variant Scores and Warfarin Effect (NCT03894878) | Cipherome, Inc. | 2019-02-11 |
Track Cipherome, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.